Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

6

Number of overlapping holdings

14.0%

% of CANC's 43 holdings also in XDNA

26.1%

% of XDNA's 23 holdings also in CANC

Overlap by Weight
Sector Drift (CANC minus XDNA)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in CANC
Weight
in XDNA
Overlap
CRISPR THERAPEUTICS AG 3.3% 15.1% 3.3%
NOVARTIS AG 3.5% 3.0% 3.0%
INTELLIA THERAPEUTICS, INC. 2.2% 8.7% 2.2%
BRISTOL-MYERS SQUIBB CO 2.0% 1.6% 1.6%
REGENERON PHARMACEUTICALS 5.4% 1.3% 1.3%

Position Highlights (Non-Overlapping Exposures)
CANC Overweight Relative to XDNA
MERCK & CO. INC. 5.1%
REGENERON PHARMACEUTICALS 4.1%
DAIICHI SANKYO CO LTD 3.8%
ASTRAZENECA PLC 3.1%
ARGENX SE ADR 2.9%
CHUGAI PHARMACEUTICAL CO LTD 2.9%
GILEAD SCIENCES INC 2.8%
ILLUMINA INC 2.8%
GUARDANT HEALTH, INC. 2.6%
INCYTE CORP 2.4%
CANC Underweight Relative to XDNA
BEAM THERAPEUTICS, INC. -13.7%
CRISPR THERAPEUTICS AG -11.8%
THERMO FISHER SCIENTIFIC INC -9.5%
INTELLIA THERAPEUTICS, INC. -6.5%
PRIME MEDICINE, INC. -5.9%
EDITAS MEDICINE, INC. -5.7%
CARIBOU BIOSCIENCES, INC. -4.7%
VERVE THERAPEUTICS, INC. -4.5%
POSEIDA THERAPEUTICS, INC. -4.1%
ABBVIE INC -3.8%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY